Alps Advisors Inc 89bio, Inc. Call Options Transaction History
Alps Advisors Inc
- $14.1 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ETNB
# of Institutions
165Shares Held
89.2MCall Options Held
584KPut Options Held
1.17M-
Janus Henderson Group PLC London, X012.6MShares$105 Million0.08% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$61.6 Million1.38% of portfolio
-
Black Rock Inc. New York, NY6.64MShares$55.4 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.3MShares$52.6 Million3.14% of portfolio
-
State Street Corp Boston, MA5.54MShares$46.3 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $388M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...